Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder

Marianna Tassinari1, Beatrice Uguagliati1, Stefania Trazzi1

  • 1Department of Biomedical and Neuromotor Science, University of Bologna, 40126 Bologna, Italy.

Insights

Brain defects in CDKL5 deficiency disorder (CDD) appear early in life, with structural alterations present in 7-day-old pups. These early changes in the Cdkl5 KO mouse model highlight the need for timely therapeutic interventions for CDD.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental condition caused by CDKL5 gene mutations.
  • The Cdkl5 KO mouse model shows brain alterations, but early-life changes remain uncharacterized.
  • Understanding early brain development in CDD is crucial for validating models and identifying treatment windows.

Purpose of the Study:

  • To investigate the presence and severity of brain alterations in young Cdkl5 KO mice.
  • To compare early-life brain development with adult stages in the CDD mouse model.
  • To identify the optimal time window for therapeutic interventions in CDD.

Main Methods:

  • Comparative analysis of cortical pyramidal neuron dendritic arborization and spines.
  • Evaluation of cortical excitatory and inhibitory connectivity.
  • Assessment of microglia activation, and granule cell proliferation/survival in the hippocampal dentate gyrus.
  • Analysis of mice at postnatal days 7, 14, 21, and 60.

Main Results:

  • Most structural brain alterations in Cdkl5 KO mice are present by postnatal day 7 and do not worsen with age.
  • An age-dependent cortical excitatory/inhibitory synaptic imbalance was observed.
  • Cdkl5 KO pups exhibit impaired neonatal sensory-motor reflexes, confirming early brain defects.

Conclusions:

  • CDD-related brain structural defects manifest precociously in early postnatal development.
  • The Cdkl5 KO mouse model accurately reflects early-onset neurological deficits in CDD.
  • These findings support early therapeutic interventions for CDD to target developmental defects.

Related Concept Videos